Peak6 Investments LLC Prothena Corp Public LTD CO Transaction History

Peak6 Investments LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$8.85 - $12.49 $66,534 - $93,899	-7,518 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$10.32 - $14.49 $381,509 - $535,666	-36,968 Reduced 83.1%	7,518 $91,000
Q4 2018 Feb 13, 2019	BUY	$8.73 - $13.74 $363,010 - $571,336	41,582 Added 1431.89%	44,486 $458,000
Q3 2018 Nov 13, 2018	BUY	$12.7 - $15.79 $36,880 - $45,854	2,904 New	2,904 $38,000

186

42.8M

162K

102K

Ticker PRTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,922,800
Market Cap $726M
Description
Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.